APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antihemorrhagic Agent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antihemorrhagic Agent Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchAntihemorrhagic Agent Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Antihemorrhagic Agent Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Antihemorrhagic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antihemorrhagic Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Antihemorrhagic Agent Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Antihemorrhagic Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antihemorrhagic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antihemorrhagic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antihemorrhagic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antihemorrhagic Agent include Biocer, C. R. Bard (BD), Celox, Equimedical, Ethicon, Gelita Medical, Hemostasis, Hemotec Medical and MBP, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antihemorrhagic Agent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antihemorrhagic Agent market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antihemorrhagic Agent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antihemorrhagic Agent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antihemorrhagic Agent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antihemorrhagic Agent Market by Company

Biocer

C. R. Bard (BD)

Celox

Equimedical

Ethicon

Gelita Medical

Hemostasis

Hemotec Medical

MBP

Medira

Starch Medical

Pfizer

Success Pharmaceutical

Changsha Hairun

Antihemorrhagic Agent Segment by Type

Microfibrillar Collagen

Chitosan

Other

Antihemorrhagic Agent Segment by Application

Surgical Wound Care

General Wound Care

Antihemorrhagic Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihemorrhagic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihemorrhagic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihemorrhagic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antihemorrhagic Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antihemorrhagic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Microfibrillar Collagen Table 2. Major Company of Chitosan Table 3. Major Company of Other Table 4. Global Antihemorrhagic Agent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antihemorrhagic Agent Sales by Type (2021-2026) & (k units) Table 6. Global Antihemorrhagic Agent Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antihemorrhagic Agent Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antihemorrhagic Agent Sales Market Share in Value by Type (2021-2026) Table 9. Global Antihemorrhagic Agent Price by Type (2021-2026) & (US$/unit) Table 10. Global Antihemorrhagic Agent Sales by Type (2027-2032) & (k units) Table 11. Global Antihemorrhagic Agent Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antihemorrhagic Agent Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antihemorrhagic Agent Sales Market Share in Value by Type (2027-2032) Table 14. Global Antihemorrhagic Agent Price by Type (2027-2032) & (US$/unit) Table 15. North America Antihemorrhagic Agent Sales by Type (2021-2026) & (k units) Table 16. North America Antihemorrhagic Agent Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antihemorrhagic Agent Sales by Type (2021-2026) & (k units) Table 18. Europe Antihemorrhagic Agent Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antihemorrhagic Agent Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Antihemorrhagic Agent Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antihemorrhagic Agent Sales by Type (2021-2026) & (k units) Table 22. Latin America Antihemorrhagic Agent Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antihemorrhagic Agent Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Antihemorrhagic Agent Sales by Type (2021-2026) & (US$ Million) Table 25. Antihemorrhagic Agent Industry Trends Table 26. Antihemorrhagic Agent Industry Drivers Table 27. Antihemorrhagic Agent Industry Opportunities and Challenges Table 28. Antihemorrhagic Agent Industry Restraints Table 29. Global Antihemorrhagic Agent Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antihemorrhagic Agent Revenue Market Share by Company (2021-2026) Table 31. Global Antihemorrhagic Agent Sales by Company (2021-2026) & (k units) Table 32. Global Antihemorrhagic Agent Sales Share by Company (2021-2026) Table 33. Global Antihemorrhagic Agent Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Antihemorrhagic Agent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antihemorrhagic Agent Major Company Production Sites and Headquarters Table 36. Global Antihemorrhagic Agent Company, Product Type & Application Table 37. Global Antihemorrhagic Agent Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antihemorrhagic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antihemorrhagic Agent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antihemorrhagic Agent Sales by Region (2021-2026) & (k units) Table 42. Global Antihemorrhagic Agent Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antihemorrhagic Agent Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antihemorrhagic Agent Sales Market Share in Value by Region (2021-2026) Table 45. Global Antihemorrhagic Agent Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Antihemorrhagic Agent Sales by Region (2027-2032) & (k units) Table 47. Global Antihemorrhagic Agent Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antihemorrhagic Agent Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antihemorrhagic Agent Sales Market Share in Value by Region (2027-2032) Table 50. Global Antihemorrhagic Agent Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Antihemorrhagic Agent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antihemorrhagic Agent Sales by Application (2021-2026) & (k units) Table 53. Global Antihemorrhagic Agent Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antihemorrhagic Agent Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antihemorrhagic Agent Sales Market Share in Value by Application (2021-2026) Table 56. Global Antihemorrhagic Agent Price by Application (2021-2026) & (US$/unit) Table 57. Global Antihemorrhagic Agent Sales by Application (2027-2032) & (k units) Table 58. Global Antihemorrhagic Agent Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antihemorrhagic Agent Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antihemorrhagic Agent Sales Market Share in Value by Application (2027-2032) Table 61. Global Antihemorrhagic Agent Price by Application (2027-2032) & (US$/unit) Table 62. North America Antihemorrhagic Agent Sales by Application (2021-2026) & (k units) Table 63. North America Antihemorrhagic Agent Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antihemorrhagic Agent Sales by Application (2021-2026) & (k units) Table 65. Europe Antihemorrhagic Agent Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antihemorrhagic Agent Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Antihemorrhagic Agent Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antihemorrhagic Agent Sales by Application (2021-2026) & (k units) Table 69. Latin America Antihemorrhagic Agent Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antihemorrhagic Agent Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Antihemorrhagic Agent Sales by Application (2021-2026) & (US$ Million) Table 72. Biocer Company Information Table 73. Biocer Business Overview Table 74. Biocer Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Biocer Antihemorrhagic Agent Product Portfolio Table 76. Biocer Recent Development Table 77. C. R. Bard (BD) Company Information Table 78. C. R. Bard (BD) Business Overview Table 79. C. R. Bard (BD) Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. C. R. Bard (BD) Antihemorrhagic Agent Product Portfolio Table 81. C. R. Bard (BD) Recent Development Table 82. Celox Company Information Table 83. Celox Business Overview Table 84. Celox Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Celox Antihemorrhagic Agent Product Portfolio Table 86. Celox Recent Development Table 87. Equimedical Company Information Table 88. Equimedical Business Overview Table 89. Equimedical Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Equimedical Antihemorrhagic Agent Product Portfolio Table 91. Equimedical Recent Development Table 92. Ethicon Company Information Table 93. Ethicon Business Overview Table 94. Ethicon Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Ethicon Antihemorrhagic Agent Product Portfolio Table 96. Ethicon Recent Development Table 97. Gelita Medical Company Information Table 98. Gelita Medical Business Overview Table 99. Gelita Medical Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Gelita Medical Antihemorrhagic Agent Product Portfolio Table 101. Gelita Medical Recent Development Table 102. Hemostasis Company Information Table 103. Hemostasis Business Overview Table 104. Hemostasis Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Hemostasis Antihemorrhagic Agent Product Portfolio Table 106. Hemostasis Recent Development Table 107. Hemotec Medical Company Information Table 108. Hemotec Medical Business Overview Table 109. Hemotec Medical Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Hemotec Medical Antihemorrhagic Agent Product Portfolio Table 111. Hemotec Medical Recent Development Table 112. MBP Company Information Table 113. MBP Business Overview Table 114. MBP Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. MBP Antihemorrhagic Agent Product Portfolio Table 116. MBP Recent Development Table 117. Medira Company Information Table 118. Medira Business Overview Table 119. Medira Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Medira Antihemorrhagic Agent Product Portfolio Table 121. Medira Recent Development Table 122. Starch Medical Company Information Table 123. Starch Medical Business Overview Table 124. Starch Medical Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Starch Medical Antihemorrhagic Agent Product Portfolio Table 126. Starch Medical Recent Development Table 127. Pfizer Company Information Table 128. Pfizer Business Overview Table 129. Pfizer Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Pfizer Antihemorrhagic Agent Product Portfolio Table 131. Pfizer Recent Development Table 132. Success Pharmaceutical Company Information Table 133. Success Pharmaceutical Business Overview Table 134. Success Pharmaceutical Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Success Pharmaceutical Antihemorrhagic Agent Product Portfolio Table 136. Success Pharmaceutical Recent Development Table 137. Changsha Hairun Company Information Table 138. Changsha Hairun Business Overview Table 139. Changsha Hairun Antihemorrhagic Agent Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Changsha Hairun Antihemorrhagic Agent Product Portfolio Table 141. Changsha Hairun Recent Development Table 142. North America Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. North America Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 144. North America Antihemorrhagic Agent Sales Market Share by Country (2021-2026) Table 145. North America Antihemorrhagic Agent Sales Forecast by Country (2027-2032) & (k units) Table 146. North America Antihemorrhagic Agent Sales Market Share Forecast by Country (2027-2032) Table 147. North America Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Antihemorrhagic Agent Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Antihemorrhagic Agent Market Share by Country (2021-2026) Table 150. North America Antihemorrhagic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Antihemorrhagic Agent Market Share Forecast by Country (2027-2032) Table 152. Europe Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Europe Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 154. Europe Antihemorrhagic Agent Sales Market Share by Country (2021-2026) Table 155. Europe Antihemorrhagic Agent Sales Forecast by Country (2027-2032) & (k units) Table 156. Europe Antihemorrhagic Agent Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Antihemorrhagic Agent Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Antihemorrhagic Agent Market Share by Country (2021-2026) Table 160. Europe Antihemorrhagic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Antihemorrhagic Agent Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 164. Asia-Pacific Antihemorrhagic Agent Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Antihemorrhagic Agent Sales Forecast by Country (2027-2032) & (k units) Table 166. Asia-Pacific Antihemorrhagic Agent Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Antihemorrhagic Agent Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Antihemorrhagic Agent Market Share by Country (2021-2026) Table 170. Asia-Pacific Antihemorrhagic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Antihemorrhagic Agent Market Share Forecast by Country (2027-2032) Table 172. Latin America Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Latin America Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 174. Latin America Antihemorrhagic Agent Sales Market Share by Country (2021-2026) Table 175. Latin America Antihemorrhagic Agent Sales Forecast by Country (2027-2032) & (k units) Table 176. Latin America Antihemorrhagic Agent Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Antihemorrhagic Agent Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Antihemorrhagic Agent Market Share by Country (2021-2026) Table 180. Latin America Antihemorrhagic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Antihemorrhagic Agent Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 184. Middle East and Africa Antihemorrhagic Agent Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Antihemorrhagic Agent Sales Forecast by Country (2027-2032) & (k units) Table 186. Middle East and Africa Antihemorrhagic Agent Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Antihemorrhagic Agent Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Antihemorrhagic Agent Market Share by Country (2021-2026) Table 190. Middle East and Africa Antihemorrhagic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Antihemorrhagic Agent Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Antihemorrhagic Agent Distributors List Table 195. Antihemorrhagic Agent Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Antihemorrhagic Agent Image Figure 2. Global Antihemorrhagic Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihemorrhagic Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Antihemorrhagic Agent Sales (2021-2032) & (k units) Figure 5. Microfibrillar Collagen Image Figure 6. Global Microfibrillar Collagen Sales YoY Growth (2021-2032) & (k units) Figure 7. Chitosan Image Figure 8. Global Chitosan Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Antihemorrhagic Agent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antihemorrhagic Agent Market Share by Type 2025 VS 2032 Figure 13. North America Antihemorrhagic Agent Sales Market Share in Volume by Type in 2025 Figure 14. North America Antihemorrhagic Agent Sales Market Share in Value by Type in 2025 Figure 15. Europe Antihemorrhagic Agent Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antihemorrhagic Agent Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antihemorrhagic Agent Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antihemorrhagic Agent Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antihemorrhagic Agent Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antihemorrhagic Agent Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antihemorrhagic Agent Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antihemorrhagic Agent Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antihemorrhagic Agent Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Surgical Wound Care Image Figure 26. Global Surgical Wound Care Sales YoY Growth (2021-2032) & (k units) Figure 27. General Wound Care Image Figure 28. Global General Wound Care Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Antihemorrhagic Agent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Antihemorrhagic Agent Market Share by Application 2025 VS 2032 Figure 31. North America Antihemorrhagic Agent Sales Market Share in Volume by Application in 2025 Figure 32. North America Antihemorrhagic Agent Sales Market Share in Value by Application in 2025 Figure 33. Europe Antihemorrhagic Agent Sales Market Share in Volume by Application in 2025 Figure 34. Europe Antihemorrhagic Agent Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Antihemorrhagic Agent Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Antihemorrhagic Agent Sales Market Share in Value by Application in 2025 Figure 37. Latin America Antihemorrhagic Agent Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Antihemorrhagic Agent Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Antihemorrhagic Agent Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Antihemorrhagic Agent Sales Market Share in Value by Application in 2025 Figure 41. North America Antihemorrhagic Agent Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Antihemorrhagic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Antihemorrhagic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Antihemorrhagic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antihemorrhagic Agent Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Antihemorrhagic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antihemorrhagic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Antihemorrhagic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antihemorrhagic Agent Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Antihemorrhagic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antihemorrhagic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Antihemorrhagic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antihemorrhagic Agent Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Antihemorrhagic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antihemorrhagic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Antihemorrhagic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antihemorrhagic Agent Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Antihemorrhagic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antihemorrhagic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Antihemorrhagic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Antihemorrhagic Agent Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Antihemorrhagic Agent Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Microfibrillar Collagen
  • Chitosan
  • Other
Applications
  • Surgical Wound Care
  • General Wound Care
Companies covered
  • Biocer
  • C. R. Bard (BD)
  • Celox
  • Equimedical
  • Ethicon
  • Gelita Medical
  • Hemostasis
  • Hemotec Medical
  • MBP
  • Medira
  • Starch Medical
  • Pfizer
  • Success Pharmaceutical
  • Changsha Hairun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antihemorrhagic Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antihemorrhagic Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antihemorrhagic Agent Market by Type
  6. 1.3.1 Microfibrillar Collagen
  7. 1.3.2 Chitosan
  8. 1.3.3 Other
  9. 1.4 Global Antihemorrhagic Agent Market Size by Type
  10. 1.4.1 Global Antihemorrhagic Agent Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antihemorrhagic Agent Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antihemorrhagic Agent Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antihemorrhagic Agent Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antihemorrhagic Agent Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antihemorrhagic Agent Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antihemorrhagic Agent Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antihemorrhagic Agent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antihemorrhagic Agent Industry Trends
  2. 2.2 Antihemorrhagic Agent Industry Drivers
  3. 2.3 Antihemorrhagic Agent Industry Opportunities and Challenges
  4. 2.4 Antihemorrhagic Agent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antihemorrhagic Agent Revenue (2021-2026)
  2. 3.2 Global Top Players by Antihemorrhagic Agent Sales (2021-2026)
  3. 3.3 Global Top Players by Antihemorrhagic Agent Price (2021-2026)
  4. 3.4 Global Antihemorrhagic Agent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antihemorrhagic Agent Major Company Production Sites & Headquarters
  6. 3.6 Global Antihemorrhagic Agent Company, Product Type & Application
  7. 3.7 Global Antihemorrhagic Agent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antihemorrhagic Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antihemorrhagic Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antihemorrhagic Agent Tier 1, Tier 2, and Tier 3
4 Antihemorrhagic Agent Regional Status and Outlook
  1. 4.1 Global Antihemorrhagic Agent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antihemorrhagic Agent Historic Market Size by Region
  3. 4.2.1 Global Antihemorrhagic Agent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antihemorrhagic Agent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antihemorrhagic Agent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antihemorrhagic Agent Forecasted Market Size by Region
  7. 4.3.1 Global Antihemorrhagic Agent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antihemorrhagic Agent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antihemorrhagic Agent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antihemorrhagic Agent by Application
  1. 5.1 Antihemorrhagic Agent Market by Application
  2. 5.1.1 Surgical Wound Care
  3. 5.1.2 General Wound Care
  4. 5.2 Global Antihemorrhagic Agent Market Size by Application
  5. 5.2.1 Global Antihemorrhagic Agent Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antihemorrhagic Agent Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antihemorrhagic Agent Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antihemorrhagic Agent Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antihemorrhagic Agent Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antihemorrhagic Agent Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antihemorrhagic Agent Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antihemorrhagic Agent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biocer
  2. 6.1.1 Biocer Company Information
  3. 6.1.2 Biocer Business Overview
  4. 6.1.3 Biocer Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biocer Antihemorrhagic Agent Product Portfolio
  6. 6.1.5 Biocer Recent Developments
  7. 6.2 C. R. Bard (BD)
  8. 6.2.1 C. R. Bard (BD) Company Information
  9. 6.2.2 C. R. Bard (BD) Business Overview
  10. 6.2.3 C. R. Bard (BD) Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 C. R. Bard (BD) Antihemorrhagic Agent Product Portfolio
  12. 6.2.5 C. R. Bard (BD) Recent Developments
  13. 6.3 Celox
  14. 6.3.1 Celox Company Information
  15. 6.3.2 Celox Business Overview
  16. 6.3.3 Celox Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Celox Antihemorrhagic Agent Product Portfolio
  18. 6.3.5 Celox Recent Developments
  19. 6.4 Equimedical
  20. 6.4.1 Equimedical Company Information
  21. 6.4.2 Equimedical Business Overview
  22. 6.4.3 Equimedical Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Equimedical Antihemorrhagic Agent Product Portfolio
  24. 6.4.5 Equimedical Recent Developments
  25. 6.5 Ethicon
  26. 6.5.1 Ethicon Company Information
  27. 6.5.2 Ethicon Business Overview
  28. 6.5.3 Ethicon Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ethicon Antihemorrhagic Agent Product Portfolio
  30. 6.5.5 Ethicon Recent Developments
  31. 6.6 Gelita Medical
  32. 6.6.1 Gelita Medical Company Information
  33. 6.6.2 Gelita Medical Business Overview
  34. 6.6.3 Gelita Medical Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gelita Medical Antihemorrhagic Agent Product Portfolio
  36. 6.6.5 Gelita Medical Recent Developments
  37. 6.7 Hemostasis
  38. 6.7.1 Hemostasis Company Information
  39. 6.7.2 Hemostasis Business Overview
  40. 6.7.3 Hemostasis Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hemostasis Antihemorrhagic Agent Product Portfolio
  42. 6.7.5 Hemostasis Recent Developments
  43. 6.8 Hemotec Medical
  44. 6.8.1 Hemotec Medical Company Information
  45. 6.8.2 Hemotec Medical Business Overview
  46. 6.8.3 Hemotec Medical Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hemotec Medical Antihemorrhagic Agent Product Portfolio
  48. 6.8.5 Hemotec Medical Recent Developments
  49. 6.9 MBP
  50. 6.9.1 MBP Company Information
  51. 6.9.2 MBP Business Overview
  52. 6.9.3 MBP Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 MBP Antihemorrhagic Agent Product Portfolio
  54. 6.9.5 MBP Recent Developments
  55. 6.10 Medira
  56. 6.10.1 Medira Company Information
  57. 6.10.2 Medira Business Overview
  58. 6.10.3 Medira Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Medira Antihemorrhagic Agent Product Portfolio
  60. 6.10.5 Medira Recent Developments
  61. 6.11 Starch Medical
  62. 6.11.1 Starch Medical Company Information
  63. 6.11.2 Starch Medical Business Overview
  64. 6.11.3 Starch Medical Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Starch Medical Antihemorrhagic Agent Product Portfolio
  66. 6.11.5 Starch Medical Recent Developments
  67. 6.12 Pfizer
  68. 6.12.1 Pfizer Company Information
  69. 6.12.2 Pfizer Business Overview
  70. 6.12.3 Pfizer Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Pfizer Antihemorrhagic Agent Product Portfolio
  72. 6.12.5 Pfizer Recent Developments
  73. 6.13 Success Pharmaceutical
  74. 6.13.1 Success Pharmaceutical Company Information
  75. 6.13.2 Success Pharmaceutical Business Overview
  76. 6.13.3 Success Pharmaceutical Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Success Pharmaceutical Antihemorrhagic Agent Product Portfolio
  78. 6.13.5 Success Pharmaceutical Recent Developments
  79. 6.14 Changsha Hairun
  80. 6.14.1 Changsha Hairun Company Information
  81. 6.14.2 Changsha Hairun Business Overview
  82. 6.14.3 Changsha Hairun Antihemorrhagic Agent Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Changsha Hairun Antihemorrhagic Agent Product Portfolio
  84. 6.14.5 Changsha Hairun Recent Developments
7 North America by Country
  1. 7.1 North America Antihemorrhagic Agent Sales by Country
  2. 7.1.1 North America Antihemorrhagic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antihemorrhagic Agent Sales by Country (2021-2026)
  4. 7.1.3 North America Antihemorrhagic Agent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antihemorrhagic Agent Market Size by Country
  6. 7.2.1 North America Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antihemorrhagic Agent Market Size by Country (2021-2026)
  8. 7.2.3 North America Antihemorrhagic Agent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antihemorrhagic Agent Sales by Country
  2. 8.1.1 Europe Antihemorrhagic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antihemorrhagic Agent Sales by Country (2021-2026)
  4. 8.1.3 Europe Antihemorrhagic Agent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antihemorrhagic Agent Market Size by Country
  6. 8.2.1 Europe Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antihemorrhagic Agent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antihemorrhagic Agent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antihemorrhagic Agent Sales by Country
  2. 9.1.1 Asia-Pacific Antihemorrhagic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antihemorrhagic Agent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antihemorrhagic Agent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antihemorrhagic Agent Market Size by Country
  6. 9.2.1 Asia-Pacific Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antihemorrhagic Agent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antihemorrhagic Agent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antihemorrhagic Agent Sales by Country
  2. 10.1.1 South America Antihemorrhagic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antihemorrhagic Agent Sales by Country (2021-2026)
  4. 10.1.3 South America Antihemorrhagic Agent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antihemorrhagic Agent Market Size by Country
  6. 10.2.1 South America Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antihemorrhagic Agent Market Size by Country (2021-2026)
  8. 10.2.3 South America Antihemorrhagic Agent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antihemorrhagic Agent Sales by Country
  2. 11.1.1 Middle East and Africa Antihemorrhagic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antihemorrhagic Agent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antihemorrhagic Agent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antihemorrhagic Agent Market Size by Country
  6. 11.2.1 Middle East and Africa Antihemorrhagic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antihemorrhagic Agent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antihemorrhagic Agent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antihemorrhagic Agent Value Chain Analysis
  2. 12.1.1 Antihemorrhagic Agent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antihemorrhagic Agent Production Mode & Process
  7. 12.2 Antihemorrhagic Agent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antihemorrhagic Agent Distributors
  10. 12.2.3 Antihemorrhagic Agent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst